Deep Medicine Acquisition Corp.
Deep Medicine Acquisition Corp. (DMAQ) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
dmaq · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Deep Medicine Acquisition Corp. (DMAQ) measures how much investors pay for each dollar of the company's trailing earnings. DMAQ's current PE ratio of N/A is calculated by dividing its stock price of $2.96 by its TTM earnings per share of -$26.57.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2021 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Deep Medicine Acquisition Corp.You DMAQ | $13M | N/A | — | -$26.57 |
 Acri Capital Acquisition Corporation ACAC | $44M | 78.94x | -59.1% | $0.14 |
 AfterNext HealthTech Acquisition Corp. AFTR-UN | $0M | 30.62x | -84.1% | $0.33 |
 Ahren Acquisition Corp. AHRN | $393M | 12.22x | -93.7% | $0.84 |
 ALSP Orchid Acquisition Corporation I ALOR | $79M | 650.95x | +237.0% | $0.02 |
 Alpha One Inc. AOAO | $49M | N/A | — | -$2.87 |
 Altimar Acquisition Corp. III ATAQF | $82M | N/A | — | $0.00 |
Industry Average 4 peers with valid PE | — | 193.18x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-51.39 | — | |
2024-12-31 FY2024 | — | $-0.76 | — | |
2023-03-31 FY2023 | — | $-0.17 | — | |
2022-03-31 FY2022 | — | $-0.04 | — | |
2021-03-31 FY2021 | — | $0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Deep Medicine Acquisition Corp. (DMAQ) measures how much investors pay for each dollar of the company's trailing earnings. DMAQ's current PE ratio of N/A is calculated by dividing its stock price of $2.96 by its TTM earnings per share of -$26.57.
Frequently asked questions
DMAQ pe ratio · 6 questionsDMAQ's current PE ratio is N/A as of 2026-06-09, based on a stock price of $2.96 and TTM EPS of -$26.57. Data sourced from Financial Modeling Prep via DMAQ's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Deep Medicine Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09